Cargando…
Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!!
COVID-19 convalescent plasma (CCP) therapy involves the use of circulating antibodies administration from recovered COVID 19 patients as a practical strategy to provide immediate passive immunity in susceptible recipients in need. Global concern over the potential for “second” or “third” waves of in...
Autores principales: | Seghatchian, Jerard, Acker, Jason P., Putter, Jeffery S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470817/ https://www.ncbi.nlm.nih.gov/pubmed/32919879 http://dx.doi.org/10.1016/j.transci.2020.102933 |
Ejemplares similares
-
Ebola virus convalescent blood products: Where we are now and where we may need to go
por: Burnouf, Thierry, et al.
Publicado: (2014) -
In vitro mass production of reproducible human cells destined for substitution therapy: Challenges for development of functional materials for what we need most in transfusion!
por: Seghatchian, Jerard
Publicado: (2020) -
The secrets of human stem cell-derived transfusable RBC for targeted large-scale production and clinical applications: A fresh look into what we need most and lessons to be learned
por: Seghatchian, Jerard
Publicado: (2020) -
An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research
por: Putter, Jeffrey S., et al.
Publicado: (2020) -
T-cell lymphocytopenia: An omnipresent predictor of morbidity and mortality in consequence of SARS-CoV disease and influenza A infections
por: Putter, Jeffrey S., et al.
Publicado: (2023)